Qureshi AR, Alvestrand A, Divino-Filho JC, Gutierrez A, Heimbürger O, Lindholm B, et al. Inflammation, Malnutrition, and Cardiac Disease as Predictors of mortality in Hemodialysis Patients. J Am Soc Nephrol. 2002;13 Suppl 1:S28-36.
Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B. The severe cardiorenal syndrome:Guyton revisited. Eur Heart J. 2005;26(1):11-7.
Herzog CA, Mangrum JM, Passman R. Non- coronary heart disease in dialysis patients: Sudden Cardiac Death and Dialysis Patients. Seminars in Dialysis. 2008;21(4):300-7. doi: 10.1111/j.1525- 139X.2008.00455.x.
Chertow GM, Burke SK, Raggi P, Treat to Goal Working Group. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Ins. 2001, 62:245- 252.
Calabrese D. Management of cardiovascular disease in chronic kidney disease:Implications for managed care. Am J Manag Care. 2011;17(Suppl. 15):S412- 8.
Foley RN, Collins AJ. A novel model of cardiovascular risk based of kidney function. Am J Nephrol. 2011;34(6):505-11. doi: 10.1159/000332997.
Goldberg A, Hammerman H, Petcherski S, Zdoro-
vyak A, Yalonetsky S, Kapeliovich M, et al. In- hospital and 1-year mortality of patients who de- velop worsening renal function following acute ST-elevation myocardial infarction. Am Heart J. 2005;150(2):330-7. doi: 10.1016/j.ahj.2004.09.055.
Thomas G, Sehgal AR, Kashyap SR, Srinivas TR, Kirwan JP, Navaneethan SD. Metabolic syndrome and kidney disease : a systematic review and meta- analysis. Clin J Am Soc Nephrol. 2011;6(10):2364- 73. doi: 10.2215/CJN.02180311.
Gottlieb SS, Abraham W, Butler J, Forman DE, Loh E, Massie BM, et al. The prognostic importance of different of worsening renal function in congestive heart failure. J Card Fail. 2008;8(3):136-41.
Hassan NA, D`Orsi ET, D`Orsi CJ, O`Neill WC. The risk for medial arterial calcification in CDK. Clin J Am Soc Nephrol. 2012 Feb;7(2):275-9. doi: 10.2215/CJN.06490711.
Resić H, Prnjavorac B, Masnić F, Ajanović S, Kukavica N, Bećiragić A. Evaluation and treatment of cardiovascular diseases in patients on hemodialysis - single center experience. Med Glas (Zenica). 2011;8(1):158-62.
Kazory A, Ross EA. Anemia: the point of convergence or divergence for kidney disease and heart failure? J Am Coll Cardiol. 2009;53(8):639- 47. doi: 10.1016/j.jacc.2008.
K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients. National Kidney Foundation. Am J Kidney Dis . 2005;45(4), Suppl. 3:1-153.
Jager KJ, Lindholm B, Goldsmith D, Fliser D, Wiecek A, Suleymanlar G, et al. Cardiovascular and non-cardiovascular mortality in dialysis patients: where is the link? ISN. Kidney Int Suppl (2011). 2011;1(1):21-3. doi: 10.1038/kisup.2011.7.
London G, Coyne D, Hruska K, Malluche HH, Martin KJ. The new kidney disease : improving global outcomes (KDIGO) guidelines - expert clinical focus on bone and vascular calcification. Clin Nephrol. 2010 Dec;74(6):423-32.
Sonician M, Parissis JT. Cardiovascular disease and hemodialysis : novel strategies for diagnosis, prevention and treatment. Hellenic J Cardiol. 2003,44:206-17.
McCullough PA, Agrawal V, Danielewicz E, Abela GS. Accelerated atherosclerotic calcification and Monckeberg`s sclerosis: a continuum of advanced
vascular pathology in chronic kidney disease. Clin J Am Soc Nephrol. 2008;3(6):1585-98. doi: 10.2215/ CJN.01930408.
Mittalhenkle A, Stehman-Breen CO, Shlipak MG, Fried LF, Katz R, Young BA, et al. Cardiovascular risk factors and incident acute renal failure in older adults: the cardiovascular health study. Clin J Am Soc Nephrol. 2008; 3(2):450-6. doi: 10.2215/ CJN.02610607.
Nohria A, Hasselblad V, Stebbins A, Pauly DF, Fonarow GC, Shah M, et al. Cardiorenal interactions : insights from the ESCAPE trial. J Am Coll Cardiol. 2008, 51(13):1268-74. doi: 10.1016/j. jacc.2007.08.072.
Palazzuoli A, Gallotta M, Iovine F, Nuti R, Silverberg DS. Anemia in heart failure : a common interaction with renal insufficiency called the cardio-renal anaemia syndrome. Int J Clin Pract. 2008;62(2):281- 6. doi: 10.1111/j.1742-1241.2007.01650.x
Parfrey PS, Lauve M, Latremouille-Viau D, Lefebvre
P. Erythropoietin therapy and left ventricular mass index in CKD and ESRD patients: a meta - analysis. Clin J Am Soc Nephrol. 2009;4(4):755-62. doi: 10.2215/CJN.02730608.
Agarwal R, Debella YT, Giduma HD, Light RP. Long
- term retinal, renal and Cardiovascular outcomes in diabetic chronic kidney disease without proteinuria. Nephrol Dial Transplant. 2012;27(1):310-7. doi: 10.1093/ndt/gfr320.
Ronco C, House AA, Haapio M. Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong. Intensive Care Med, 2008;34(5):957-62. doi: 10.1007/s00134-008-1017- 8.
Rucker D, Tonelli M. Cardiovascular risk and management in chronic kidney disease. Nat Rev Nephrol. 2009;5:287-96. doi:10.1038/nrne- ph.2009.42.
Veila S, Silva V, et al. Cardiovascular disease in patients with ESRD on hemodialysis in developing country. Saudy J Kidney Dis Transp. 2012;23(2):262-6.
Slinin Y, Foley RN, Collins AJ. Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study. J Am Soc Nephrol. 2005;16(6):1788-93. doi: 10.1681/ASN.2004040275.